Spinocerebellar Ataxia Type 2

The beneficial effect of thalamic deep brain stimulation (DBS) on action tremor has been reported in a few cases of spinocerebellar ataxia (SCA); however, several factors should be taken into account regarding the indication for DBS in advanced cases.

Isobe et al. performed DBS of the ventral intermediate nucleus (Vim) of the thalamus for treatment of coarse action tremor in a patient with SCA2 (spinocerebellar ataxia type 2) in the wheelchair-bound stage. Although improvement of the tremor of the proximal part was incomplete, the patient regained substantial parts of daily functioning. The effect lasted for more than 6 years, and the suppression of tremor significantly contributed to maintaining the level of the patient's expression into the bedridden stage. Vim DBS can be a treatment option for tremor in SCA patients, even in the advanced stage, as long as the tremor is depriving the patient of behavioral expression. As residual proximal tremor may hamper functional recovery, DBS of other targets or multi-targets should be further explored to attain a better outcome ¹⁾.

2: Robinson-Agramonte MLA, Gonçalves CA, Farina de Almeida R, González Quevedo A, Chow S, Velázquez Pérez L, Díaz de la Fé A, Sesterheim P, Souza DOG. Neuroinflammation and Neuromodulation in Neurological Diseases. Behav Sci (Basel). 2019 Sep 12;9(9). pii: E99. doi: 10.3390/bs9090099. PubMed PMID: 31547441; PubMed Central PMCID: PMC6770731.

3: Todaro V, Larner AJ. An unusual cause of clumsiness: spinocerebellar ataxia type 2. Br J Hosp Med (Lond). 2019 Jul 2;80(7):ii. doi: 10.12968/hmed.2019.80.7.ii. PubMed PMID: 31283387.

4: Diallo A, Jacobi H, Cook A, Giunti P, Parkinson MH, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Castaldo A, Rakowicz M, Rola R, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Nachbauer W, Pandolfo M, Schulz JB, Bauer P, Jun-Suk K, Klockgether T, Tezenas du Montcel S. Prediction of Survival With Long-Term Disease Progression in Most Common Spinocerebellar Ataxia. Mov Disord. 2019 Aug;34(8):1220-1227. doi: 10.1002/mds.27739. Epub 2019 Jun 18. PubMed PMID: 31211461.

5: Genis D, Ortega-Cubero S, San Nicolás H, Corral J, Gardenyes J, de Jorge L, López E, Campos B, Lorenzo E, Tonda R, Beltran S, Negre M, Obón M, Beltran B, Fàbregas L, Alemany B, Márquez F, Ramió-Torrentà L, Gich J, Volpini V, Pastor P. Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48). Neurology. 2018 Nov 20;91(21):e1988-e1998. doi: 10.1212/WNL.0000000000006550. Epub 2018 Oct 31. PubMed PMID: 30381368.

6: Gentil BJ, Lai GT, Menade M, Larivière R, Minotti S, Gehring K, Chapple JP, Brais B, Durham HD. Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics. FASEB J. 2019 Feb;33(2):2982-2994. doi: 10.1096/fj.201801556R. Epub 2018 Oct 17. PubMed PMID: 30332300.

7: Yau WY, O'Connor E, Sullivan R, Akijian L, Wood NW. DNA repair in trinucleotide repeat ataxias. FEBS J. 2018 Oct;285(19):3669-3682. doi: 10.1111/febs.14644. Epub 2018 Sep 10. Review. PubMed PMID: 30152109.

8: Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Sarro L, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Nachbauer W, Kang JS, Pandolfo M, Schulz JB, Melac AT, Diallo A, Klockgether T. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias. J Neurol. 2018 Sep;265(9):2040-2051. doi: 10.1007/s00415-018-8954-0. Epub 2018 Jun 29. PubMed PMID: 29959555.

9: Ménade M, Kozlov G, Trempe JF, Pande H, Shenker S, Wickremasinghe S, Li X, Hojjat H, Dicaire MJ, Brais B, McPherson PS, Wong MJH, Young JC, Gehring K. Structures of ubiquitin-like (Ubl) and Hsp90-like domains of sacsin provide insight into pathological mutations. J Biol Chem. 2018 Aug 17;293(33):12832-12842. doi: 10.1074/jbc.RA118.003939. Epub 2018 Jun 26. PubMed PMID: 29945973; PubMed Central PMCID: PMC6102131.

10: Hare N, Georgopoulos P, Philips KE, Johnson JE, Seary C, Panicker JN, Stevenson VL. Improvement in overactive bladder symptoms in patients using functional electrical stimulation of the common peroneal nerve for walking. Clin Rehabil. 2018 Oct;32(10):1357-1362. doi: 10.1177/0269215518780974. Epub 2018 Jun 17. PubMed PMID: 29909652.

11: Wang RY, Huang FY, Soong BW, Huang SF, Yang YR. A randomized controlled pilot trial of game-based training in individuals with spinocerebellar ataxia type 3. Sci Rep. 2018 May 18;8(1):7816. doi: 10.1038/s41598-018-26109-w. PubMed PMID: 29777115; PubMed Central PMCID: PMC5959926.

12: Ahmad H, Requena T, Frejo L, Cobo M, Gallego-Martinez A, Martin F, Lopez-Escamez JA, Bronstein AM. Clinical and Functional Characterization of a Missense ELF2 Variant in a CANVAS Family. Front Genet. 2018 Mar 23;9:85. doi: 10.3389/fgene.2018.00085. eCollection 2018. PubMed PMID: 29628936; PubMed Central PMCID: PMC5876245.

13: Chelban V, Wiethoff S, Fabian-Jessing BK, Haridy NA, Khan A, Efthymiou S, Becker EBE, O'Connor E, Hersheson J, Newland K, Hojland AT, Gregersen PA, Lindquist SG, Petersen MB, Nielsen JE, Nielsen M, Wood NW, Giunti P, Houlden H. Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14. Mov Disord. 2018 Jul;33(7):1119-1129. doi: 10.1002/mds.27334. Epub 2018 Mar 30. PubMed PMID: 29603387; PubMed Central PMCID: PMC6175136.

14: Diallo A, Jacobi H, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schmitz-Hübsch T, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Kang JS, Klockgether T, Tezenas du Montcel S. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study. Lancet Neurol. 2018 Apr;17(4):327-334. doi: 10.1016/S1474-4422(18)30042-5. Epub 2018 Mar 13. PubMed PMID: 29553382.

15: Parkinson MH, Bartmann AP, Clayton LMS, Nethisinghe S, Pfundt R, Chapple JP, Reilly MM, Manji H, Wood NJ, Bremner F, Giunti P. Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Brain. 2018 Apr 1;141(4):989-999. doi: 10.1093/brain/awy028. PubMed PMID: 29538656.

16: Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K, Prokisch H, Rossignol E, Helm MH, Rodan LH, Karamchandani J, Carecchio M, Lubbe SJ, Telegrafi A, Henderson LB, Lorenzo K, Wallace SE, Glass IA, Hamdan FF, Michaud JL, Rouleau GA, Campeau PM. Recessive mutations in VPS13D cause childhood onset movement disorders. Ann Neurol. 2018 Jun;83(6):1089-1095. doi: 10.1002/ana.25204. Epub 2018 Apr 10. PubMed PMID: 29518281.

17: Estévez-Báez M, Machado C, Montes-Brown J, Jas-García J, Leisman G, Schiavi A, Machado-García A, Carricarte-Naranjo C, Carmeli E. Very High Frequency Oscillations of Heart Rate Variability in Healthy Humans and in Patients with Cardiovascular Autonomic Neuropathy. Adv Exp Med Biol. 2018;1070:49-70. doi: 10.1007/5584_2018_154. PubMed PMID: 29429029.

18: Hsieh J, Liu JW, Harn HJ, Hsueh KW, Rajamani K, Deng YC, Chia CM, Shyu WC, Lin SZ, Chiou TW. Human Olfactory Ensheathing Cell Transplantation Improves Motor Function in a Mouse Model of Type 3 Spinocerebellar Ataxia. Cell Transplant. 2017 Oct;26(10):1611-1621. doi: 10.1177/0963689717732578. PubMed PMID: 29251109; PubMed Central PMCID: PMC5753984.

19: Gauquelin L, Tétreault M, Thiffault I, Farrow E, Miller N, Yoo B, Bareke E, Yoon G, Suchowersky O, Dupré N, Tarnopolsky M, Brais B, Wolf NI, Majewski J, Rouleau GA, Gan-Or Z, Bernard G. POLR3A variants in hereditary spastic paraplegia and ataxia. Brain. 2018 Jan 1;141(1):e1. doi: 10.1093/brain/awx290. PubMed PMID: 29228109; PubMed Central PMCID: PMC5837469.

20: Diallo A, Jacobi H, Schmitz-Hübsch T, Cook A, Labrum R, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sobanska A, Sulek A, Schöls L, Hengel H, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Boesch S, Pandolfo M, Schulz JB, Bauer P, Giunti P, Baliko L, Parkinson MH, Kang JS, Klockgether T, Tezenas du Montcel S. Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression. Mov Disord Clin Pract. 2017 Aug 11;4(5):689-697. doi: 10.1002/mdc3.12522. eCollection 2017 Sep-Oct. PubMed PMID: 30363449; PubMed Central PMCID: PMC6174467.

21: Seixas AI, Loureiro JR, Costa C, Ordóñez-Ugalde A, Marcelino H, Oliveira CL, Loureiro JL, Dhingra A, Brandão E, Cruz VT, Timóteo A, Quintáns B, Rouleau GA, Rizzu P, Carracedo Á, Bessa J, Heutink P, Sequeiros J, Sobrido MJ, Coutinho P, Silveira I. A Pentanucleotide ATTTC Repeat Insertion in the Non-coding Region of DAB1, Mapping to SCA37, Causes Spinocerebellar Ataxia. Am J Hum Genet. 2017 Jul 6;101(1):87-103. doi: 10.1016/j.ajhg.2017.06.007. PubMed PMID: 28686858; PubMed Central PMCID: PMC5501871.

22: Chelban V, Patel N, Vandrovcova J, Zanetti MN, Lynch DS, Ryten M, Botía JA, Bello O, Tribollet E, Efthymiou S, Davagnanam I; SYNAPSE Study Group, Bashiri FA, Wood NW, Rothman JE, Alkuraya FS, Houlden H. Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination. Am J Hum Genet. 2017 Jun 1;100(6):969-977. doi: 10.1016/j.ajhg.2017.05.009. PubMed PMID: 28575651; PubMed Central PMCID: PMC5473715.

23: Duncan EJ, Larivière R, Bradshaw TY, Longo F, Sgarioto N, Hayes MJ, Romano LEL, Nethisinghe S, Giunti P, Bruntraeger MB, Durham HD, Brais B, Maltecca F, Gentil BJ, Chapple JP. Altered organization of the intermediate filament cytoskeleton and relocalization of proteostasis modulators in cells lacking the ataxia protein sacsin. Hum Mol Genet. 2017 Aug 15;26(16):3130-3143. doi: 10.1093/hmg/ddx197. PubMed PMID: 28535259; PubMed Central PMCID: PMC5886247.

24: Cornelius N, Wardman JH, Hargreaves IP, Neergheen V, Bie AS, Tümer Z, Nielsen JE, Nielsen TT. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters. Mitochondrion. 2017 May;34:103-114. doi: 10.1016/j.mito.2017.03.001. Epub 2017 Mar 3. PubMed PMID: 28263872.

25: Beaudin M, Klein CJ, Rouleau GA, Dupré N. Systematic review of autosomal recessive ataxias and proposal for a classification. Cerebellum Ataxias. 2017 Feb 23;4:3. doi: 10.1186/s40673-017-0061-y. eCollection 2017. Review. PubMed PMID: 28250961; PubMed Central PMCID: PMC5324265.

26: Rajamani K, Liu JW, Wu CH, Chiang IT, You DH, Lin SY, Hsieh DK, Lin SZ, Harn HJ, Chiou TW. n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3. Neuropharmacology. 2017 May 1;117:434-446. doi: 10.1016/j.neuropharm.2017.02.014. Epub 2017 Feb 20. PubMed PMID: 28223212.

27: Ratnaparkhe M, Hlevnjak M, Kolb T, Jauch A, Maass KK, Devens F, Rode A, Hovestadt V, Korshunov A, Pastorczak A, Mlynarski W, Sungalee S, Korbel J, Hoell J, Fischer U, Milde T, Kramm C, Nathrath M, Chrzanowska K, Tausch E, Takagi M, Taga T, Constantini S, Loeffen J, Meijerink J, Zielen S, Gohring G, Schlegelberger B, Maass E, Siebert R, Kunz J, Kulozik AE, Worst B, Jones DT, Pfister SM, Zapatka M, Lichter P, Ernst A. Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis. Leukemia. 2017 Oct;31(10):2048-2056. doi: 10.1038/leu.2017.55. Epub 2017 Feb 15. PubMed PMID: 28196983.

28: Tipton PW, Guthrie K, Strongosky A, Reimer R, Wszolek ZK. Spinocerebellar ataxia 15: A phenotypic review and expansion. Neurol Neurochir Pol. 2017 Jan - Feb;51(1):86-91. doi: 10.1016/j.pjnns.2016.10.006. Epub 2016 Nov 10. Review. PubMed PMID: 27908616; PubMed Central PMCID: PMC5378493.

29: Moriarty A, Cook A, Hunt H, Adams ME, Cipolotti L, Giunti P. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. Orphanet J Rare Dis. 2016 Jun 22;11(1):82. doi: 10.1186/s13023-016-0447-6. PubMed PMID: 27333979; PubMed Central PMCID: PMC4917932.

30: Wang Y, Hersheson J, Lopez D, Hammer M, Liu Y, Lee KH, Pinto V, Seinfeld J, Wiethoff S, Sun J, Amouri R, Hentati F, Baudry N, Tran J, Singleton AB, Coutelier M, Brice A, Stevanin G, Durr A, Bi X, Houlden H, Baudry M. Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans. Cell Rep. 2016 Jun 28;16(1):79-91. doi: 10.1016/j.celrep.2016.05.044. Epub 2016 Jun 16. PubMed PMID: 27320912; PubMed Central PMCID: PMC4927383.

31: Wiethoff S, Hersheson J, Bettencourt C, Wood NW, Houlden H. Heterogeneity in clinical features and disease severity in ataxia-associated SYNE1 mutations. J Neurol. 2016 Aug;263(8):1503-10. doi: 10.1007/s00415-016-8148-6. Epub 2016 May 13. PubMed PMID: 27178001; PubMed Central PMCID: PMC4971038.

32: Bettencourt C, Hensman-Moss D, Flower M, Wiethoff S, Brice A, Goizet C, Stevanin G, Koutsis G, Karadima G, Panas M, Yescas-Gómez P, García-Velázquez LE, Alonso-Vilatela ME, Lima M, Raposo M, Traynor B, Sweeney M, Wood N, Giunti P; SPATAX Network, Durr A, Holmans P, Houlden H, Tabrizi SJ, Jones L. DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Ann Neurol. 2016 Jun;79(6):983-90. doi: 10.1002/ana.24656. Epub 2016 May 6. PubMed PMID: 27044000; PubMed Central PMCID: PMC4914895.

33: Pedroso JL, Braga-Neto P, Escorcio-Bezerra ML, Abrahão A, de Albuquerque MV, Filho FM, de Souza PV, de Rezende Pinto WB, Borges FR Jr, Saraiva-Pereira ML, Jardim LB, Barsottini OG. Non-motor and Extracerebellar Features in Spinocerebellar Ataxia Type 2. Cerebellum. 2017 Feb;16(1):34-39. doi: 10.1007/s12311-016-0761-5. PubMed PMID: 26825292.

34: Bezerra ML, Pedroso JL, Braga-Neto P, Abrahao A, de Albuquerque MV, Borges FR Jr, Saraiva-Pereira ML, Jardim LB, de Oliveira Braga NI, Manzano GM, Barsottini OG. Pattern of Peripheral Nerve Involvement in Spinocerebellar Ataxia Type 2: a Neurophysiological Assessment. Cerebellum. 2016 Dec;15(6):767-773. PubMed PMID: 26708559.

35: Choquet K, Tétreault M, Yang S, La Piana R, Dicaire MJ, Vanstone MR, Mathieu J, Bouchard JP, Rioux MF, Rouleau GA; Care4Rare Canada Consortium, Boycott KM, Majewski J, Brais B. SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases. Eur J Hum Genet. 2016 Jul;24(7):1016-21. doi: 10.1038/ejhg.2015.240. Epub 2015 Dec 2. PubMed PMID: 26626314; PubMed Central PMCID: PMC5070891.

36: Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, Parkinson MH, Durr A, Brice A, Charles P, Marelli C, Mariotti C, Nanetti L, Panzeri M, Rakowicz M, Sulek A, Sobanska A, Schmitz-Hübsch T, Schöls L, Hengel H, Baliko L, Melegh B, Filla A, Antenora A, Infante J, Berciano J, van de Warrenburg BP, Timmann D, Szymanski S, Boesch S, Kang JS, Pandolfo M, Schulz JB, Molho S, Diallo A, Klockgether T. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 2015 Nov;14(11):1101-8. doi: 10.1016/S1474-4422(15)00202-1. Epub 2015 Sep 13. PubMed PMID: 26377379.

37: Braga-Neto P, Pedroso JL, Gadelha A, Laureano MR, de Souza Noto C, Garrido GJ, Barsottini OG. Psychosis in Machado-Joseph Disease: Clinical Correlates, Pathophysiological Discussion, and Functional Brain Imaging. Expanding the Cerebellar Cognitive Affective Syndrome. Cerebellum. 2016 Aug;15(4):483-90. doi: 10.1007/s12311-015-0716-2. PubMed PMID: 26298474.

38: Bourassa CV, Raskin S, Serafini S, Teive HA, Dion PA, Rouleau GA. A New ELOVL4 Mutation in a Case of Spinocerebellar Ataxia With Erythrokeratodermia. JAMA Neurol. 2015 Aug;72(8):942-3. doi: 10.1001/jamaneurol.2015.0888. PubMed PMID: 26258735.

39: Pedroso JL, de Souza PV, Pinto WB, Braga-Neto P, Albuquerque MV, Saraiva-Pereira ML, Jardim LB, Barsottini OG. SCA1 patients may present as hereditary spastic paraplegia and must be included in spastic-ataxias group. Parkinsonism Relat Disord. 2015 Oct;21(10):1243-6. doi: 10.1016/j.parkreldis.2015.07.015. Epub 2015 Jul 22. PubMed PMID: 26231471.

40: Akizu N, Cantagrel V, Zaki MS, Al-Gazali L, Wang X, Rosti RO, Dikoglu E, Gelot AB, Rosti B, Vaux KK, Scott EM, Silhavy JL, Schroth J, Copeland B, Schaffer AE, Gordts PL, Esko JD, Buschman MD, Field SJ, Napolitano G, Abdel-Salam GM, Ozgul RK, Sagıroglu MS, Azam M, Ismail S, Aglan M, Selim L, Mahmoud IG, Abdel-Hadi S, Badawy AE, Sadek AA, Mojahedi F, Kayserili H, Masri A, Bastaki L, Temtamy S, Müller U, Desguerre I, Casanova JL, Dursun A, Gunel M, Gabriel SB, de Lonlay P, Gleeson JG. Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction. Nat Genet. 2015 May;47(5):528-34. doi: 10.1038/ng.3256. Epub 2015 Apr 6. PubMed PMID: 25848753; PubMed Central PMCID: PMC4414867.

41: Jobling RK, Assoum M, Gakh O, Blaser S, Raiman JA, Mignot C, Roze E, Dürr A, Brice A, Lévy N, Prasad C, Paton T, Paterson AD, Roslin NM, Marshall CR, Desvignes JP, Roëckel-Trevisiol N, Scherer SW, Rouleau GA, Mégarbané A, Isaya G, Delague V, Yoon G. PMPCA mutations cause abnormal mitochondrial protein processing in patients with non-progressive cerebellar ataxia. Brain. 2015 Jun;138(Pt 6):1505-17. doi: 10.1093/brain/awv057. Epub 2015 Mar 25. PubMed PMID: 25808372; PubMed Central PMCID: PMC4542620.

42: Babuska V, Houdek Z, Tuma J, Purkartova Z, Tumova J, Kralickova M, Vozeh F, Cendelin J. Transplantation of Embryonic Cerebellar Grafts Improves Gait Parameters in Ataxic Lurcher Mice. Cerebellum. 2015 Dec;14(6):632-41. doi: 10.1007/s12311-015-0656-x. PubMed PMID: 25700681.

43: Anzak A, Little S, Hulse N, Andrews T, Brown P, Samuel M, Ashkan K. Excessive neural synchrony in Machado-Joseph disease responsive to subthalamic nucleus stimulation. Mov Disord. 2015 Mar;30(3):437-8. doi: 10.1002/mds.26173. Epub 2015 Feb 17. PubMed PMID: 25689061.

44: Reetz K, Dogan I, Costa AS, Dafotakis M, Fedosov K, Giunti P, Parkinson MH, Sweeney MG, Mariotti C, Panzeri M, Nanetti L, Arpa J, Sanz-Gallego I, Durr A, Charles P, Boesch S, Nachbauer W, Klopstock T, Karin I, Depondt C, vom Hagen JM, Schöls L, Giordano IA, Klockgether T, Bürk K, Pandolfo M, Schulz JB. Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol. 2015 Feb;14(2):174-82. doi: 10.1016/S1474-4422(14)70321-7. Epub 2015 Jan 5. PubMed PMID: 25566998.

45: Choquet K, La Piana R, Brais B. A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia. Neurogenetics. 2015 Jul;16(3):233-6. doi: 10.1007/s10048-014-0436-7. Epub 2015 Jan 8. PubMed PMID: 25566820.

46: Larivière R, Gaudet R, Gentil BJ, Girard M, Conte TC, Minotti S, Leclerc-Desaulniers K, Gehring K, McKinney RA, Shoubridge EA, McPherson PS, Durham HD, Brais B. Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay. Hum Mol Genet. 2015 Feb 1;24(3):727-39. doi: 10.1093/hmg/ddu491. Epub 2014 Sep 26. PubMed PMID: 25260547; PubMed Central PMCID: PMC4291249.

47: Oyama G, Thompson A, Foote KD, Limotai N, Abd-El-Barr M, Maling N, Malaty IA, Rodriguez RL, Subramony SH, Ashizawa T, Okun MS. Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y). 2014 Jul 9;4:228. doi: 10.7916/D8542KQ5. eCollection 2014. Erratum in: Tremor Other Hyperkinet Mov (N Y). 2016;6:418. PubMed PMID: 25120941; PubMed Central PMCID: PMC4101398.

48: Yu Z, Jia H, Xu Y, You C. [Hereditary spinocerebellar ataxia-a pedigree with six cases]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Aug;31(4):536. doi: 10.3760/cma.j.issn.1003-9406.2014.04.033. Chinese. PubMed PMID: 25119928.

49: Herrema H, Mikkelsen T, Robin A, LeWitt P, Sidiropoulos C. SCA 17 phenotype with intermediate triplet repeat number. J Neurol Sci. 2014 Oct 15;345(1-2):269-70. doi: 10.1016/j.jns.2014.07.041. Epub 2014 Jul 26. PubMed PMID: 25091452.

50: Martins S, Pearson CE, Coutinho P, Provost S, Amorim A, Dubé MP, Sequeiros J, Rouleau GA. Modifiers of (CAG)(n) instability in Machado-Joseph disease (MJD/SCA3) transmissions: an association study with DNA replication, repair and recombination genes. Hum Genet. 2014 Oct;133(10):1311-8. doi: 10.1007/s00439-014-1467-8. Epub 2014 Jul 16. PubMed PMID: 25026993.

51: Doherty KM, Warner TT, Lees AJ. Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma. Mov Disord. 2014 Jan;29(1):36-8. doi: 10.1002/mds.25770. Epub 2013 Dec 16. PubMed PMID: 24343983.

52: Braga-Neto P, Dutra LA, Pedroso JL, Barsottini OG. Cognitive dysfunction in spinocerebellar ataxia type 3: variable topographies and patterns. Mov Disord. 2014 Jan;29(1):156-7. doi: 10.1002/mds.25756. Epub 2013 Dec 11. PubMed PMID: 24338620.

53: Escorcio Bezerra ML, Pedroso JL, Pinheiro DS, Braga-Neto P, Povoas Barsottini OG, Braga NI, Manzano GM. Pattern of peripheral nerve involvement in Machado-Joseph disease: neuronopathy or distal axonopathy? A clinical and neurophysiological evaluation. Eur Neurol. 2013;69(3):129-33. doi: 10.1159/000345274. Epub 2012 Dec 7. PubMed PMID: 23234876.

54: Fawcett K, Mehrabian M, Liu YT, Hamed S, Elahi E, Revesz T, Koutsis G, Herscheson J, Schottlaender L, Wardle M, Morrison PJ, Morris HR, Giunti P, Wood N, Houlden H. The frequency of spinocerebellar ataxia type 23 in a UK population. J Neurol. 2013 Mar;260(3):856-9. doi: 10.1007/s00415-012-6721-1. Epub 2012 Oct 30. Erratum in: J Neurol. 2013 Mar;260(3):860. PubMed PMID: 23108490.

55: Pedroso JL, Bor-Seng-Shu E, Felicio AC, Braga-Neto P, Dutra LA, de Aquino CC, Ferraz HB, do Prado GF, Teixeira MJ, Barsottini OG. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation. J Neurol Sci. 2012 Aug 15;319(1-2):59-62. doi: 10.1016/j.jns.2012.05.015. Epub 2012 May 24. PubMed PMID: 22632781.

56: Braga-Neto P, Felicio AC, Hoexter MQ, Pedroso JL, Dutra LA, Alessi H, Minett T, Santos-Galduroz RF, da Rocha AJ, Garcia LA, Bertolucci PH, Bressan RA, Barsottini OG. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study. Parkinsonism Relat Disord. 2012 Aug;18(7):854-8. doi: 10.1016/j.parkreldis.2012.04.015. Epub 2012 May 8. PubMed PMID: 22575233.

57: Braga-Neto P, Dutra LA, Pedroso JL, Felício AC, Alessi H, Santos-Galduroz RF, Bertolucci PH, Castiglioni ML, Bressan RA, de Garrido GE, Barsottini OG, Jackowski A. Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas. Cerebellum. 2012 Dec;11(4):1037-44. doi: 10.1007/s12311-012-0354-x. PubMed PMID: 22307858.

58: Girard M, Larivière R, Parfitt DA, Deane EC, Gaudet R, Nossova N, Blondeau F, Prenosil G, Vermeulen EG, Duchen MR, Richter A, Shoubridge EA, Gehring K, McKinney RA, Brais B, Chapple JP, McPherson PS. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):1661-6. doi: 10.1073/pnas.1113166109. Epub 2012 Jan 17. PubMed PMID: 22307627; PubMed Central PMCID: PMC3277168.

59: Raso A, Vecchio D, Cappelli E, Ropolo M, Poggi A, Nozza P, Biassoni R, Mascelli S, Capra V, Kalfas F, Severi P, Frosina G. Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein. Brain Pathol. 2012 Sep;22(5):677-88. doi: 10.1111/j.1750-3639.2012.00566.x. Epub 2012 Feb 21. PubMed PMID: 22257080.

60: Braga-Neto P, Pedroso JL, Alessi H, Dutra LA, Felício AC, Minett T, Weisman P, Santos-Galduroz RF, Bertolucci PH, Gabbai AA, Barsottini OG. Cerebellar cognitive affective syndrome in Machado Joseph disease: core clinical features. Cerebellum. 2012 Jun;11(2):549-56. doi: 10.1007/s12311-011-0318-6. PubMed PMID: 21975858.

61: Pedroso JL, Bor-Seng-Shu E, Felício AC, Braga-Neto P, Teixeira MJ, Barsottini OG. Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): a cross-sectional study. Neurosci Lett. 2011 Oct 24;504(2):98-101. doi: 10.1016/j.neulet.2011.09.006. Epub 2011 Sep 12. PubMed PMID: 21939734.

62: Pedroso JL, Bezerra ML, Braga-Neto P, Pinheiro DS, Minett T, do Prado GF, Manzano GM, Barsottini OG. Is neuropathy involved with restless legs syndrome in Machado-Joseph disease? Eur Neurol. 2011;66(4):200-3. doi: 10.1159/000331008. Epub 2011 Sep 20. PubMed PMID: 21934311.

63: Pedroso JL, Braga-Neto P, Abrahão A, Rivero RL, Abdalla C, Abdala N, Barsottini OG. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family. Arq Neuropsiquiatr. 2011;69(2B):288-91. PubMed PMID: 21625752.

64: Pedroso JL, Braga-Neto P, Felício AC, Aquino CC, Prado LB, Prado GF, Barsottini OG. Sleep disorders in cerebellar ataxias. Arq Neuropsiquiatr. 2011 Apr;69(2A):253-7. Review. PubMed PMID: 21537570.

65: Braga-Neto P, Felicio AC, Pedroso JL, Dutra LA, Bertolucci PH, Gabbai AA, Barsottini OG. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2011 Jun;17(5):353-6. doi: 10.1016/j.parkreldis.2011.02.004. Epub 2011 Mar 1. PubMed PMID: 21367642.

66: Pedroso JL, Braga-Neto P, Felício AC, Dutra LA, Santos WA, do Prado GF, Barsottini OG. Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features. Cerebellum. 2011 Jun;10(2):291-5. doi: 10.1007/s12311-011-0252-7. PubMed PMID: 21287304.

67: Durcan TM, Fon EA. Mutant ataxin-3 promotes the autophagic degradation of parkin. Autophagy. 2011 Feb;7(2):233-4. Epub 2011 Feb 1. PubMed PMID: 21116127.

68: Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA. The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet. 2011 Jan 1;20(1):141-54. doi: 10.1093/hmg/ddq452. Epub 2010 Oct 11. PubMed PMID: 20940148; PubMed Central PMCID: PMC3005906.

69: Sokolovsky N, Cook A, Hunt H, Giunti P, Cipolotti L. A preliminary characterisation of cognition and social cognition in spinocerebellar ataxia types 2, 1, and 7. Behav Neurol. 2010;23(1-2):17-29. doi: 10.3233/BEN-2010-0270. Erratum in: Behav Neurol. 2010;23(3):159. Behav Neurol. 2010;23 (3):159. PubMed PMID: 20714058; PubMed Central PMCID: PMC5434399.

70: Novak MJ, Sweeney MG, Li A, Treacy C, Chandrashekar HS, Giunti P, Goold RG, Davis MB, Houlden H, Tabrizi SJ. An ITPR1 gene deletion causes spinocerebellar ataxia 15/16: a genetic, clinical and radiological description. Mov Disord. 2010 Oct 15;25(13):2176-82. doi: 10.1002/mds.23223. PubMed PMID: 20669319.

71: Baker M. Tumours spark stem-cell review. Nature. 2009 Feb 19;457(7232):941. doi: 10.1038/457941a. PubMed PMID: 19238682.

72: Bernard G, Shevell M. The wobbly child: an approach to inherited ataxias. Semin Pediatr Neurol. 2008 Dec;15(4):194-208. doi: 10.1016/j.spen.2008.10.011. PubMed PMID: 19073328.

73: Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP, Rossor MN, Davis MB, Tabrizi SJ. Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord. 2008 Apr 15;23(5):716-20. doi: 10.1002/mds.21915. PubMed PMID: 18181206.

74: Wild EJ, Tabrizi SJ. The differential diagnosis of chorea. Pract Neurol. 2007 Nov;7(6):360-73. Review. PubMed PMID: 18024776.

75: Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol. 2007 Dec;20(6):681-7. Review. PubMed PMID: 17992089.

76: Hamel W, Herzog J, Kopper F, Pinsker M, Weinert D, Müller D, Krack P, Deuschl G, Mehdorn HM. Deep brain stimulation in the subthalamic area is more effective than nucleus ventralis intermedius stimulation for bilateral intention tremor. Acta Neurochir (Wien). 2007 Aug;149(8):749-58; discussion 758. Epub 2007 Aug 1. PubMed PMID: 17660940.

77: Greenfield J, Treacy C, Giunti P. Centres of Excellence for the care of people with progressive ataxias. Br J Nurs. 2006 Sep 28-Oct 11;15(17):932-6. Review. PubMed PMID: 17077786.

78: Masri AT, Bakri FG, Al-Hadidy AM, Musharbash AF, Al-Hussaini M. Ataxia-telangiectasia complicated by craniopharyngioma–a new observation. Pediatr Neurol. 2006 Oct;35(4):287-8. PubMed PMID: 16996406.

79: Hiramoto K, Kawakami H, Inoue K, Seki T, Maruyama H, Morino H, Matsumoto M, Kurisu K, Sakai N. Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4. Mov Disord. 2006 Sep;21(9):1355-60. PubMed PMID: 16763984.

80: Loy CT, Sweeney MG, Davis MB, Wills AJ, Sawle GV, Lees AJ, Tabrizi SJ. Spinocerebellar ataxia type 17: extension of phenotype with putaminal rim hyperintensity on magnetic resonance imaging. Mov Disord. 2005 Nov;20(11):1521-3. PubMed PMID: 16037935.

81: Viscomi MT, Florenzano F, Amadio S, Bernardi G, Molinari M. Partial resistance of ataxin-2-containing olivary and pontine neurons to axotomy-induced degeneration. Brain Res Bull. 2005 Aug 15;66(3):212-21. PubMed PMID: 16023918.

82: Kuoppamäki M, Giunti P, Quinn N, Wood NW, Bhatia KP. Slowly progressive cerebellar ataxia and cervical dystonia: clinical presentation of a new form of spinocerebellar ataxia? Mov Disord. 2003 Feb;18(2):200-6. Review. PubMed PMID: 12539216.

83: Zhang W, Lee WH, Triarhou LC. Grafted cerebellar cells in a mouse model of hereditary ataxia express IGF-I system genes and partially restore behavioral function. Nat Med. 1996 Jan;2(1):65-71. PubMed PMID: 8564845.

84: Miyagi K, Mukawa J, Kinjo N, Horikawa K, Mekaru S, Nakasone S, Koga H, Higa Y, Naito M. Astrocytoma linked to familial ataxia-telangiectasia. Acta Neurochir (Wien). 1995;135(1-2):87-92. PubMed PMID: 8748798.